Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Repurchased
Ratios

Haemonetics (HAE) EBIAT (2016 - 2025)

Historic EBIAT for Haemonetics (HAE) over the last 17 years, with Q4 2025 value amounting to $44.7 million.

  • Haemonetics' EBIAT rose 1932.58% to $44.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $175.4 million, marking a year-over-year increase of 3488.33%. This contributed to the annual value of $167.7 million for FY2025, which is 4263.51% up from last year.
  • Latest data reveals that Haemonetics reported EBIAT of $44.7 million as of Q4 2025, which was up 1932.58% from $38.7 million recorded in Q3 2025.
  • In the past 5 years, Haemonetics' EBIAT registered a high of $58.0 million during Q1 2025, and its lowest value of -$11.0 million during Q2 2021.
  • Its 5-year average for EBIAT is $27.5 million, with a median of $32.1 million in 2022.
  • In the last 5 years, Haemonetics' EBIAT plummeted by 16264.75% in 2021 and then surged by 54627.3% in 2022.
  • Quarter analysis of 5 years shows Haemonetics' EBIAT stood at $14.9 million in 2021, then skyrocketed by 121.76% to $32.9 million in 2022, then dropped by 5.17% to $31.2 million in 2023, then increased by 20.02% to $37.5 million in 2024, then increased by 19.33% to $44.7 million in 2025.
  • Its last three reported values are $44.7 million in Q4 2025, $38.7 million for Q3 2025, and $34.0 million during Q2 2025.